Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Investor Presentation
Intimation of Q4 & FY21 Earnings Presentation15-05-2021
15-05-2021
Rossari Biotech Ltd - 543213 - Grant Of Options Under Rossari Employee Stock Option Plan - 2019
Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Grant of Options under Rossari Employee Stock Option Plan - 2019.14-05-2021
Rossari Biotech Ltd - 543213 - Board recommends Final Dividend
Rossari Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2021, inter alia, has recommended a Final Dividend of 25% (i.e. Re. 0.50/- per share) on Equity Shares of the Face Value of Rs. 2/- each for the Financial Year ended March 31, 2021 subject to approval by the shareholders at the forthcoming Annual General Meeting the Company.14-05-2021
Rossari Biotech Ltd - 543213 - Outcome Of Board Meeting Held On Friday, May 14, 2021
The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2021 of the financial year 2020-21 and other matters.14-05-2021
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings Conference Call for investors and analysts on Monday, May 17, 202107-05-2021
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of News Paper Publication of Notice of Board Meeting scheduled to be held on Friday, May 14, 202107-05-2021
Rossari Biotech Ltd - 543213 - Board to consider Final Dividend
Rossari Biotech Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 14, 2021, inter alia, to consider and approve the following:1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2021, and2. To recommend payment of final dividend, if any, for the financial year ended March 31, 2021.Further, vide the Company's letter dated March 31, 2021, the "Trading Window" for dealing in the securities of the Company shall remain closed for all the "Designated Persons and their immediate relatives" covered under Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders (Code of Conduct) from January 01, 2021 till 48 hours after the announcement of Audited Financial Results of the Company for the quarter and financial year ended March 31, 2021.06-05-2021
Rossari Biotech Ltd - 543213 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On Friday, May 14, 2021
Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2021 ,inter alia, to consider and approve Meeting Board of Directors of the Company is scheduled to be held on Friday, May 14, 2021,inter alia, To consider and approve the financial results for the period ended March 31, 2021 and recommend payment of Final Dividend, if any, for the financial year ended March 31, 2021.06-05-2021
Rossari Biotech Ltd - 543213 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayRossari Biotech Ltd 2CINL24100MH2009PLC194818 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: Parul Gupta Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Manasi Nisal Designation: Chief Financial Officer EmailId: [email protected] Date: 23/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.23-04-2021